⌘K

Home/Filings/4/0001213900-25-006639

4//SEC Filing

WILSON GLYNN 4

Accession 0001213900-25-006639

CIK 0001937993other

View on SEC.gov Company Profile

Filed

Jan 23, 7:00 PM ET

Accepted

Jan 24, 6:13 PM ET

Size

5.3 KB

Accession

0001213900-25-006639

Insider Transaction Report

Form 4

Period: 2025-01-23

Cadrenal Therapeutics, Inc.CVKD

Director

Transactions

Award
Stock Options
2025-01-23+20,000→ 20,000 total
Exercise: $19.79From: 2025-02-01Exp: 2035-01-22→ Common Stock (20,000 underlying)

Footnotes (1)

[F1]These options vest pro rata on a monthly basis over 12 months commencing on February 1, 2025.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Cadrenal Therapeutics, Inc.

CIK 0001937993

Entity typeother

Related Parties

1

filerCIK 0001405625

Filing Metadata

Form type: 4
Filed: Jan 23, 7:00 PM ET
Accepted: Jan 24, 6:13 PM ET
Size: 5.3 KB

View on SEC.gov